NCT00972816 Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years) Status COMPLETED Phase PHASE2/PHASE3
NCT00972517 Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children Status COMPLETED Phase PHASE3
NCT00971425 Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) Status COMPLETED Phase PHASE3
NCT00971321 Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) Status COMPLETED Phase PHASE2
NCT00968890 Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly Status COMPLETED Phase PHASE2
NCT00968539 Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults Status COMPLETED Phase PHASE3
NCT00968526 Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults Status COMPLETED Phase PHASE3
NCT00966238 Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age Status COMPLETED Phase PHASE2
NCT00964951 CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations Status WITHDRAWN Phase PHASE2
NCT00964158 Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) Status COMPLETED Phase PHASE3
NCT00963157 Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations Status COMPLETED Phase PHASE2
NCT00959049 A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population Status COMPLETED Phase PHASE3
NCT00958243 A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA Status COMPLETED Phase PHASE2
NCT00958126 A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA Status COMPLETED Phase PHASE2